Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Testosterone vs Estring for Vaginal Dryness in Breast Cancer Patients on AIs
NCT00698035Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2007
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Testosterone TEPI patch in Vulvovaginal atrophy (VVA), hypoactive sexual desire disorder (HSDD), sponsored by University of California, San Francisco. Started Mar 2007; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Vulvovaginal atrophy (VVA)hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00698035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698035.